mirikizumab

Eli Lilly, Crohn's disease, ulcerative colitis, mirikizumab, Clinical trial data, Stelara
Latest News Clinical Trials Pharma

Lilly’s mirikizumab shows promise in Crohn’s disease after failing in psoriasis

Anika Sharma

After a previous setback when the FDA withheld approval for mirikizumab in ulcerative colitis due to manufacturing issues, Eli Lilly’s ...

nice omvoh ulcerative colitis, lilly omvoh fda rejection, omvoh oral drug for ulcerative colitis, nice cost-effectiveness omvoh, omvoh clinical benefits ulcerative colitis, lilly omvoh approval status, omvoh safety concerns fda
Latest News Approvals Pharma

NICE approves Lilly’s Omvoh for ulcerative colitis after FDA rejection, citing cost-effectiveness and clinical benefits

Anika Sharma

“In a significant turn of events, Eli Lilly, despite initial setbacks in the US market with its ulcerative colitis drug ...

Pharmtales - your go-to source for comprehensive coverage of the pharmaceutical industry.

pharmtales
Latest Pharma News & Insights

Š 2024 pharmtales.com | All rights reserved.

PRIVACY POLICY terms of service Contact us